Loading…

Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer’s disease

Sporadic and familial Alzheimer’s disease differ in region-specific amyloid-β accumulation, pattern of neurodegeneration, and symptoms. Shinohara et al. quantify amyloid-β, tau and related molecules and reveal a synapse-associated pattern of amyloid-β42 in sporadic disease, and APP-associated amyloi...

Full description

Saved in:
Bibliographic Details
Published in:Brain (London, England : 1878) England : 1878), 2014-05, Vol.137 (5), p.1533-1549
Main Authors: Shinohara, Mitsuru, Fujioka, Shinsuke, Murray, Melissa E., Wojtas, Aleksandra, Baker, Matthew, Rovelet-Lecrux, Anne, Rademakers, Rosa, Das, Pritam, Parisi, Joseph E., Graff-Radford, Neill R., Petersen, Ronald C., Dickson, Dennis W., Bu, Guojun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c479t-1e9371b267ce2307a8191ef96231e2c9bddff949e361e1e77f3309dc8ed4403d3
cites cdi_FETCH-LOGICAL-c479t-1e9371b267ce2307a8191ef96231e2c9bddff949e361e1e77f3309dc8ed4403d3
container_end_page 1549
container_issue 5
container_start_page 1533
container_title Brain (London, England : 1878)
container_volume 137
creator Shinohara, Mitsuru
Fujioka, Shinsuke
Murray, Melissa E.
Wojtas, Aleksandra
Baker, Matthew
Rovelet-Lecrux, Anne
Rademakers, Rosa
Das, Pritam
Parisi, Joseph E.
Graff-Radford, Neill R.
Petersen, Ronald C.
Dickson, Dennis W.
Bu, Guojun
description Sporadic and familial Alzheimer’s disease differ in region-specific amyloid-β accumulation, pattern of neurodegeneration, and symptoms. Shinohara et al. quantify amyloid-β, tau and related molecules and reveal a synapse-associated pattern of amyloid-β42 in sporadic disease, and APP-associated amyloid-β42 in familial cases. Aberrant synaptic processes and APP processing respectively may drive these differences. Recent studies suggest that subcortical structures, including striatum, are vulnerable to amyloid-β accumulation and other neuropathological features in familial Alzheimer’s disease due to autosomal dominant mutations. We explored differences between familial and sporadic Alzheimer’s disease that might shed light on their respective pathogenic mechanisms. To this end, we analysed 12 brain regions, including neocortical, limbic and subcortical areas, from post-mortem brains of familial Alzheimer’s disease (n = 10; age at death: 50.0 ± 8.6 years) with mutations in amyloid precursor protein (APP) or presenilin 1 (PSEN1), sporadic Alzheimer’s disease (n = 19; age at death: 84.7 ± 7.8 years), neurologically normal elderly without amyloid-β accumulation (normal ageing; n = 13, age at death: 82.9 ± 10.8 years) and neurologically normal elderly with extensive cortical amyloid-β deposits (pathological ageing; n = 15; age at death: 92.7 ± 5.9 years). The levels of amyloid-β40, amyloid-β42, APP, apolipoprotein E, the synaptic marker PSD95 (now known as DLG4), the astrocyte marker GFAP, other molecules related to amyloid-β metabolism, and tau were determined by enzyme-linked immunosorbent assays. We observed that familial Alzheimer’s disease had disproportionate amyloid-β42 accumulation in subcortical areas compared with sporadic Alzheimer’s disease, whereas sporadic Alzheimer’s disease had disproportionate amyloid-β42 accumulation in cortical areas compared to familial Alzheimer’s disease. Compared with normal ageing, the levels of several proteins involved in amyloid-β metabolism were significantly altered in both sporadic and familial Alzheimer’s disease; however, such changes were not present in pathological ageing. Among molecules related to amyloid-β metabolism, the regional distribution of PSD95 strongly correlated with the regional pattern of amyloid-β42 accumulation in sporadic Alzheimer’s disease and pathological ageing, whereas the regional distribution of APP as well as β-C-terminal fragment of APP were strongly associated with the regional pattern o
doi_str_mv 10.1093/brain/awu046
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3999719</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/brain/awu046</oup_id><sourcerecordid>1519839747</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-1e9371b267ce2307a8191ef96231e2c9bddff949e361e1e77f3309dc8ed4403d3</originalsourceid><addsrcrecordid>eNqNkc-OFCEQhztG446rN8-Gi9GD7UJDN83FZLLxX7KJG6NnQtPFDEpDC7Sb9eRLePD1fBKZnXHVi_FEKnz1UcWvqu4T_JRgQU-GqKw_URcLZt2NakVYh-uGtN3NaoUx7upetPioupPSB4wJo013uzpqWNe0nWhX1be3sLHBK4dGm3K0w5JLiYJB6dKrOVuNJhU_QkxI-RGtz8-RDjGCUxnQhc3bqz7rdUbaWW91mFXeBhc2VhepAZWXCAlZj9IcohqLcCcyarLOFmLtvmzBThB_fP2edjJQCe5Wt4xyCe4dzuPq_Yvn705f1WdvXr4-XZ_VmnGRawKCcjI0HdfQUMxVTwQBI7qGEmi0GMbRGMEE0I4AAc4NpViMuoeRMUxHelw923vnZZhg1OBzVE7O0ZalL2VQVv594-1WbsJnSYUQnIgieHwQxPBpgZTlZJMG55SHsCRJWsr6tmG8-Q-UiJ4KznhBn-xRHUNKEcz1RATLXejyKnS5D73gD_7c4hr-lXIBHh4AlUoqJiqvbfrN9eU3OCOFe7TnwjL_-8mfnO7Jmw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1519839747</pqid></control><display><type>article</type><title>Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer’s disease</title><source>Oxford Journals Online</source><creator>Shinohara, Mitsuru ; Fujioka, Shinsuke ; Murray, Melissa E. ; Wojtas, Aleksandra ; Baker, Matthew ; Rovelet-Lecrux, Anne ; Rademakers, Rosa ; Das, Pritam ; Parisi, Joseph E. ; Graff-Radford, Neill R. ; Petersen, Ronald C. ; Dickson, Dennis W. ; Bu, Guojun</creator><creatorcontrib>Shinohara, Mitsuru ; Fujioka, Shinsuke ; Murray, Melissa E. ; Wojtas, Aleksandra ; Baker, Matthew ; Rovelet-Lecrux, Anne ; Rademakers, Rosa ; Das, Pritam ; Parisi, Joseph E. ; Graff-Radford, Neill R. ; Petersen, Ronald C. ; Dickson, Dennis W. ; Bu, Guojun</creatorcontrib><description>Sporadic and familial Alzheimer’s disease differ in region-specific amyloid-β accumulation, pattern of neurodegeneration, and symptoms. Shinohara et al. quantify amyloid-β, tau and related molecules and reveal a synapse-associated pattern of amyloid-β42 in sporadic disease, and APP-associated amyloid-β42 in familial cases. Aberrant synaptic processes and APP processing respectively may drive these differences. Recent studies suggest that subcortical structures, including striatum, are vulnerable to amyloid-β accumulation and other neuropathological features in familial Alzheimer’s disease due to autosomal dominant mutations. We explored differences between familial and sporadic Alzheimer’s disease that might shed light on their respective pathogenic mechanisms. To this end, we analysed 12 brain regions, including neocortical, limbic and subcortical areas, from post-mortem brains of familial Alzheimer’s disease (n = 10; age at death: 50.0 ± 8.6 years) with mutations in amyloid precursor protein (APP) or presenilin 1 (PSEN1), sporadic Alzheimer’s disease (n = 19; age at death: 84.7 ± 7.8 years), neurologically normal elderly without amyloid-β accumulation (normal ageing; n = 13, age at death: 82.9 ± 10.8 years) and neurologically normal elderly with extensive cortical amyloid-β deposits (pathological ageing; n = 15; age at death: 92.7 ± 5.9 years). The levels of amyloid-β40, amyloid-β42, APP, apolipoprotein E, the synaptic marker PSD95 (now known as DLG4), the astrocyte marker GFAP, other molecules related to amyloid-β metabolism, and tau were determined by enzyme-linked immunosorbent assays. We observed that familial Alzheimer’s disease had disproportionate amyloid-β42 accumulation in subcortical areas compared with sporadic Alzheimer’s disease, whereas sporadic Alzheimer’s disease had disproportionate amyloid-β42 accumulation in cortical areas compared to familial Alzheimer’s disease. Compared with normal ageing, the levels of several proteins involved in amyloid-β metabolism were significantly altered in both sporadic and familial Alzheimer’s disease; however, such changes were not present in pathological ageing. Among molecules related to amyloid-β metabolism, the regional distribution of PSD95 strongly correlated with the regional pattern of amyloid-β42 accumulation in sporadic Alzheimer’s disease and pathological ageing, whereas the regional distribution of APP as well as β-C-terminal fragment of APP were strongly associated with the regional pattern of amyloid-β42 accumulation in familial Alzheimer’s disease. Apolipoprotein E and GFAP showed negative regional association with amyloid-β (especially amyloid-β40) accumulation in both sporadic and familial Alzheimer’s disease. Familial Alzheimer’s disease had greater striatal tau pathology than sporadic Alzheimer’s disease. In a retrospective medical record review, atypical signs and symptoms were more frequent in familial Alzheimer’s disease compared with sporadic Alzheimer’s disease. These results suggest that disproportionate amyloid-β42 accumulation in cortical areas in sporadic Alzheimer’s disease may be mediated by synaptic processes, whereas disproportionate amyloid-β42 accumulation in subcortical areas in familial Alzheimer’s disease may be driven by APP and its processing. Region-specific amyloid-β42 accumulation might account for differences in the relative amounts of tau pathology and clinical symptoms in familial and sporadic Alzheimer’s disease.</description><identifier>ISSN: 0006-8950</identifier><identifier>EISSN: 1460-2156</identifier><identifier>DOI: 10.1093/brain/awu046</identifier><identifier>PMID: 24625695</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Adult and adolescent clinical studies ; Aged ; Aged, 80 and over ; Alzheimer Disease - classification ; Alzheimer Disease - genetics ; Alzheimer Disease - pathology ; Amyloid beta-Peptides - metabolism ; Amyloid beta-Protein Precursor - metabolism ; Amyloid Precursor Protein Secretases - metabolism ; Aspartic Acid Endopeptidases - metabolism ; Biological and medical sciences ; Brain - metabolism ; Brain - pathology ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Female ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Humans ; Male ; Medical sciences ; Middle Aged ; Nerve Tissue Proteins - metabolism ; Nervous system (semeiology, syndromes) ; Neurofibrillary Tangles - pathology ; Neurology ; Organic mental disorders. Neuropsychology ; Original ; Postmortem Changes ; Presenilin-1 - genetics ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Synapses - metabolism ; Synapses - pathology ; tau Proteins - metabolism</subject><ispartof>Brain (London, England : 1878), 2014-05, Vol.137 (5), p.1533-1549</ispartof><rights>The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2014</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-1e9371b267ce2307a8191ef96231e2c9bddff949e361e1e77f3309dc8ed4403d3</citedby><cites>FETCH-LOGICAL-c479t-1e9371b267ce2307a8191ef96231e2c9bddff949e361e1e77f3309dc8ed4403d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28440741$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24625695$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shinohara, Mitsuru</creatorcontrib><creatorcontrib>Fujioka, Shinsuke</creatorcontrib><creatorcontrib>Murray, Melissa E.</creatorcontrib><creatorcontrib>Wojtas, Aleksandra</creatorcontrib><creatorcontrib>Baker, Matthew</creatorcontrib><creatorcontrib>Rovelet-Lecrux, Anne</creatorcontrib><creatorcontrib>Rademakers, Rosa</creatorcontrib><creatorcontrib>Das, Pritam</creatorcontrib><creatorcontrib>Parisi, Joseph E.</creatorcontrib><creatorcontrib>Graff-Radford, Neill R.</creatorcontrib><creatorcontrib>Petersen, Ronald C.</creatorcontrib><creatorcontrib>Dickson, Dennis W.</creatorcontrib><creatorcontrib>Bu, Guojun</creatorcontrib><title>Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer’s disease</title><title>Brain (London, England : 1878)</title><addtitle>Brain</addtitle><description>Sporadic and familial Alzheimer’s disease differ in region-specific amyloid-β accumulation, pattern of neurodegeneration, and symptoms. Shinohara et al. quantify amyloid-β, tau and related molecules and reveal a synapse-associated pattern of amyloid-β42 in sporadic disease, and APP-associated amyloid-β42 in familial cases. Aberrant synaptic processes and APP processing respectively may drive these differences. Recent studies suggest that subcortical structures, including striatum, are vulnerable to amyloid-β accumulation and other neuropathological features in familial Alzheimer’s disease due to autosomal dominant mutations. We explored differences between familial and sporadic Alzheimer’s disease that might shed light on their respective pathogenic mechanisms. To this end, we analysed 12 brain regions, including neocortical, limbic and subcortical areas, from post-mortem brains of familial Alzheimer’s disease (n = 10; age at death: 50.0 ± 8.6 years) with mutations in amyloid precursor protein (APP) or presenilin 1 (PSEN1), sporadic Alzheimer’s disease (n = 19; age at death: 84.7 ± 7.8 years), neurologically normal elderly without amyloid-β accumulation (normal ageing; n = 13, age at death: 82.9 ± 10.8 years) and neurologically normal elderly with extensive cortical amyloid-β deposits (pathological ageing; n = 15; age at death: 92.7 ± 5.9 years). The levels of amyloid-β40, amyloid-β42, APP, apolipoprotein E, the synaptic marker PSD95 (now known as DLG4), the astrocyte marker GFAP, other molecules related to amyloid-β metabolism, and tau were determined by enzyme-linked immunosorbent assays. We observed that familial Alzheimer’s disease had disproportionate amyloid-β42 accumulation in subcortical areas compared with sporadic Alzheimer’s disease, whereas sporadic Alzheimer’s disease had disproportionate amyloid-β42 accumulation in cortical areas compared to familial Alzheimer’s disease. Compared with normal ageing, the levels of several proteins involved in amyloid-β metabolism were significantly altered in both sporadic and familial Alzheimer’s disease; however, such changes were not present in pathological ageing. Among molecules related to amyloid-β metabolism, the regional distribution of PSD95 strongly correlated with the regional pattern of amyloid-β42 accumulation in sporadic Alzheimer’s disease and pathological ageing, whereas the regional distribution of APP as well as β-C-terminal fragment of APP were strongly associated with the regional pattern of amyloid-β42 accumulation in familial Alzheimer’s disease. Apolipoprotein E and GFAP showed negative regional association with amyloid-β (especially amyloid-β40) accumulation in both sporadic and familial Alzheimer’s disease. Familial Alzheimer’s disease had greater striatal tau pathology than sporadic Alzheimer’s disease. In a retrospective medical record review, atypical signs and symptoms were more frequent in familial Alzheimer’s disease compared with sporadic Alzheimer’s disease. These results suggest that disproportionate amyloid-β42 accumulation in cortical areas in sporadic Alzheimer’s disease may be mediated by synaptic processes, whereas disproportionate amyloid-β42 accumulation in subcortical areas in familial Alzheimer’s disease may be driven by APP and its processing. Region-specific amyloid-β42 accumulation might account for differences in the relative amounts of tau pathology and clinical symptoms in familial and sporadic Alzheimer’s disease.</description><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alzheimer Disease - classification</subject><subject>Alzheimer Disease - genetics</subject><subject>Alzheimer Disease - pathology</subject><subject>Amyloid beta-Peptides - metabolism</subject><subject>Amyloid beta-Protein Precursor - metabolism</subject><subject>Amyloid Precursor Protein Secretases - metabolism</subject><subject>Aspartic Acid Endopeptidases - metabolism</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>Brain - pathology</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Female</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurofibrillary Tangles - pathology</subject><subject>Neurology</subject><subject>Organic mental disorders. Neuropsychology</subject><subject>Original</subject><subject>Postmortem Changes</subject><subject>Presenilin-1 - genetics</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Synapses - metabolism</subject><subject>Synapses - pathology</subject><subject>tau Proteins - metabolism</subject><issn>0006-8950</issn><issn>1460-2156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqNkc-OFCEQhztG446rN8-Gi9GD7UJDN83FZLLxX7KJG6NnQtPFDEpDC7Sb9eRLePD1fBKZnXHVi_FEKnz1UcWvqu4T_JRgQU-GqKw_URcLZt2NakVYh-uGtN3NaoUx7upetPioupPSB4wJo013uzpqWNe0nWhX1be3sLHBK4dGm3K0w5JLiYJB6dKrOVuNJhU_QkxI-RGtz8-RDjGCUxnQhc3bqz7rdUbaWW91mFXeBhc2VhepAZWXCAlZj9IcohqLcCcyarLOFmLtvmzBThB_fP2edjJQCe5Wt4xyCe4dzuPq_Yvn705f1WdvXr4-XZ_VmnGRawKCcjI0HdfQUMxVTwQBI7qGEmi0GMbRGMEE0I4AAc4NpViMuoeRMUxHelw923vnZZhg1OBzVE7O0ZalL2VQVv594-1WbsJnSYUQnIgieHwQxPBpgZTlZJMG55SHsCRJWsr6tmG8-Q-UiJ4KznhBn-xRHUNKEcz1RATLXejyKnS5D73gD_7c4hr-lXIBHh4AlUoqJiqvbfrN9eU3OCOFe7TnwjL_-8mfnO7Jmw</recordid><startdate>20140501</startdate><enddate>20140501</enddate><creator>Shinohara, Mitsuru</creator><creator>Fujioka, Shinsuke</creator><creator>Murray, Melissa E.</creator><creator>Wojtas, Aleksandra</creator><creator>Baker, Matthew</creator><creator>Rovelet-Lecrux, Anne</creator><creator>Rademakers, Rosa</creator><creator>Das, Pritam</creator><creator>Parisi, Joseph E.</creator><creator>Graff-Radford, Neill R.</creator><creator>Petersen, Ronald C.</creator><creator>Dickson, Dennis W.</creator><creator>Bu, Guojun</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20140501</creationdate><title>Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer’s disease</title><author>Shinohara, Mitsuru ; Fujioka, Shinsuke ; Murray, Melissa E. ; Wojtas, Aleksandra ; Baker, Matthew ; Rovelet-Lecrux, Anne ; Rademakers, Rosa ; Das, Pritam ; Parisi, Joseph E. ; Graff-Radford, Neill R. ; Petersen, Ronald C. ; Dickson, Dennis W. ; Bu, Guojun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-1e9371b267ce2307a8191ef96231e2c9bddff949e361e1e77f3309dc8ed4403d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alzheimer Disease - classification</topic><topic>Alzheimer Disease - genetics</topic><topic>Alzheimer Disease - pathology</topic><topic>Amyloid beta-Peptides - metabolism</topic><topic>Amyloid beta-Protein Precursor - metabolism</topic><topic>Amyloid Precursor Protein Secretases - metabolism</topic><topic>Aspartic Acid Endopeptidases - metabolism</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>Brain - pathology</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Female</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurofibrillary Tangles - pathology</topic><topic>Neurology</topic><topic>Organic mental disorders. Neuropsychology</topic><topic>Original</topic><topic>Postmortem Changes</topic><topic>Presenilin-1 - genetics</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Synapses - metabolism</topic><topic>Synapses - pathology</topic><topic>tau Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shinohara, Mitsuru</creatorcontrib><creatorcontrib>Fujioka, Shinsuke</creatorcontrib><creatorcontrib>Murray, Melissa E.</creatorcontrib><creatorcontrib>Wojtas, Aleksandra</creatorcontrib><creatorcontrib>Baker, Matthew</creatorcontrib><creatorcontrib>Rovelet-Lecrux, Anne</creatorcontrib><creatorcontrib>Rademakers, Rosa</creatorcontrib><creatorcontrib>Das, Pritam</creatorcontrib><creatorcontrib>Parisi, Joseph E.</creatorcontrib><creatorcontrib>Graff-Radford, Neill R.</creatorcontrib><creatorcontrib>Petersen, Ronald C.</creatorcontrib><creatorcontrib>Dickson, Dennis W.</creatorcontrib><creatorcontrib>Bu, Guojun</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Brain (London, England : 1878)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shinohara, Mitsuru</au><au>Fujioka, Shinsuke</au><au>Murray, Melissa E.</au><au>Wojtas, Aleksandra</au><au>Baker, Matthew</au><au>Rovelet-Lecrux, Anne</au><au>Rademakers, Rosa</au><au>Das, Pritam</au><au>Parisi, Joseph E.</au><au>Graff-Radford, Neill R.</au><au>Petersen, Ronald C.</au><au>Dickson, Dennis W.</au><au>Bu, Guojun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer’s disease</atitle><jtitle>Brain (London, England : 1878)</jtitle><addtitle>Brain</addtitle><date>2014-05-01</date><risdate>2014</risdate><volume>137</volume><issue>5</issue><spage>1533</spage><epage>1549</epage><pages>1533-1549</pages><issn>0006-8950</issn><eissn>1460-2156</eissn><abstract>Sporadic and familial Alzheimer’s disease differ in region-specific amyloid-β accumulation, pattern of neurodegeneration, and symptoms. Shinohara et al. quantify amyloid-β, tau and related molecules and reveal a synapse-associated pattern of amyloid-β42 in sporadic disease, and APP-associated amyloid-β42 in familial cases. Aberrant synaptic processes and APP processing respectively may drive these differences. Recent studies suggest that subcortical structures, including striatum, are vulnerable to amyloid-β accumulation and other neuropathological features in familial Alzheimer’s disease due to autosomal dominant mutations. We explored differences between familial and sporadic Alzheimer’s disease that might shed light on their respective pathogenic mechanisms. To this end, we analysed 12 brain regions, including neocortical, limbic and subcortical areas, from post-mortem brains of familial Alzheimer’s disease (n = 10; age at death: 50.0 ± 8.6 years) with mutations in amyloid precursor protein (APP) or presenilin 1 (PSEN1), sporadic Alzheimer’s disease (n = 19; age at death: 84.7 ± 7.8 years), neurologically normal elderly without amyloid-β accumulation (normal ageing; n = 13, age at death: 82.9 ± 10.8 years) and neurologically normal elderly with extensive cortical amyloid-β deposits (pathological ageing; n = 15; age at death: 92.7 ± 5.9 years). The levels of amyloid-β40, amyloid-β42, APP, apolipoprotein E, the synaptic marker PSD95 (now known as DLG4), the astrocyte marker GFAP, other molecules related to amyloid-β metabolism, and tau were determined by enzyme-linked immunosorbent assays. We observed that familial Alzheimer’s disease had disproportionate amyloid-β42 accumulation in subcortical areas compared with sporadic Alzheimer’s disease, whereas sporadic Alzheimer’s disease had disproportionate amyloid-β42 accumulation in cortical areas compared to familial Alzheimer’s disease. Compared with normal ageing, the levels of several proteins involved in amyloid-β metabolism were significantly altered in both sporadic and familial Alzheimer’s disease; however, such changes were not present in pathological ageing. Among molecules related to amyloid-β metabolism, the regional distribution of PSD95 strongly correlated with the regional pattern of amyloid-β42 accumulation in sporadic Alzheimer’s disease and pathological ageing, whereas the regional distribution of APP as well as β-C-terminal fragment of APP were strongly associated with the regional pattern of amyloid-β42 accumulation in familial Alzheimer’s disease. Apolipoprotein E and GFAP showed negative regional association with amyloid-β (especially amyloid-β40) accumulation in both sporadic and familial Alzheimer’s disease. Familial Alzheimer’s disease had greater striatal tau pathology than sporadic Alzheimer’s disease. In a retrospective medical record review, atypical signs and symptoms were more frequent in familial Alzheimer’s disease compared with sporadic Alzheimer’s disease. These results suggest that disproportionate amyloid-β42 accumulation in cortical areas in sporadic Alzheimer’s disease may be mediated by synaptic processes, whereas disproportionate amyloid-β42 accumulation in subcortical areas in familial Alzheimer’s disease may be driven by APP and its processing. Region-specific amyloid-β42 accumulation might account for differences in the relative amounts of tau pathology and clinical symptoms in familial and sporadic Alzheimer’s disease.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>24625695</pmid><doi>10.1093/brain/awu046</doi><tpages>17</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-8950
ispartof Brain (London, England : 1878), 2014-05, Vol.137 (5), p.1533-1549
issn 0006-8950
1460-2156
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3999719
source Oxford Journals Online
subjects Adult
Adult and adolescent clinical studies
Aged
Aged, 80 and over
Alzheimer Disease - classification
Alzheimer Disease - genetics
Alzheimer Disease - pathology
Amyloid beta-Peptides - metabolism
Amyloid beta-Protein Precursor - metabolism
Amyloid Precursor Protein Secretases - metabolism
Aspartic Acid Endopeptidases - metabolism
Biological and medical sciences
Brain - metabolism
Brain - pathology
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Female
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Humans
Male
Medical sciences
Middle Aged
Nerve Tissue Proteins - metabolism
Nervous system (semeiology, syndromes)
Neurofibrillary Tangles - pathology
Neurology
Organic mental disorders. Neuropsychology
Original
Postmortem Changes
Presenilin-1 - genetics
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Synapses - metabolism
Synapses - pathology
tau Proteins - metabolism
title Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer’s disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T12%3A40%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regional%20distribution%20of%20synaptic%20markers%20and%20APP%20correlate%20with%20distinct%20clinicopathological%20features%20in%20sporadic%20and%20familial%20Alzheimer%E2%80%99s%20disease&rft.jtitle=Brain%20(London,%20England%20:%201878)&rft.au=Shinohara,%20Mitsuru&rft.date=2014-05-01&rft.volume=137&rft.issue=5&rft.spage=1533&rft.epage=1549&rft.pages=1533-1549&rft.issn=0006-8950&rft.eissn=1460-2156&rft_id=info:doi/10.1093/brain/awu046&rft_dat=%3Cproquest_pubme%3E1519839747%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c479t-1e9371b267ce2307a8191ef96231e2c9bddff949e361e1e77f3309dc8ed4403d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1519839747&rft_id=info:pmid/24625695&rft_oup_id=10.1093/brain/awu046&rfr_iscdi=true